Patterns of MMP-2 and MMP-9 expression in human cancer cell lines

Oncology Reports

Volumn 21, Issue 5, 2009, Pages 1323-1333

  Roomi, M W ^a   Monterrey, J C ^a   Kalinovsky, T ^a   Rath, M ^a   Niedzwiecki, Aleksandra ^a  

^a Dr Rath Research Institute   (United States)

Author keywords

Human cancer cell lines; MMP 2; MMP 9

Indexed keywords

GELATINASE A; GELATINASE B;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME RELEASE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL LINE, TUMOR; ENZYME INDUCTION; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NEOPLASMS; TETRADECANOYLPHORBOL ACETATE;

EID: 67649336792     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000358     Document Type: Article

References (29)

1. Fidler IJ: Molecular biology of cancer: invasion and metastasis. In: Cancer: Principles and Practice of Oncology. 5th edition. De Vita VT, Hellman S and Rosenberg SA (eds). Lippincott-Raven, Philadelphia, PA, pp135-152, 1997.
2. Egeblad M and Werb Z: New functions for the matrix metallo-proteinases in cancer progression. Nat Rev Cancer 2: 161-174, 2002.
3. Folkman J: Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29 (Suppl. 16): S15-S18, 2002.
4. Chambers AF and Matrisian LM: Changing views on the role of matrix metalloprotenases in metastasis. J Natl Cancer Inst 89: 1260-1270, 1997.
5. Kleiner DL and Stetler-Stevenson WG: Matrix metallo-proteinases and metastasis. Cancer Chemother Pharmacol (Suppl) 43: S42-S51, 1999.
6. Yurchenko PD and Schitny JC: Molecular architecture of basement memebranes. FASEB J 4: 1577-1590, 1990.
7. Barsky SH, Siegel GP, Jannotta F and Liotta LA: Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest 49: 140-147, 1983.
8. Liotta LA, Tryggvason K, Garbisa A, Hart I, Foltz CM and Shafie S: Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284: 67-68, 1980.
9. Stetler-Stevenson WG: The role of matrix metalloproteinases in tumor invasion, metastasis and angiogenesis. Surg Oncol Clin N Am 10: 383-392, 2001.
10. Stetler-Stevenson WG: Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev 9: 289-303, 1990.
11. Woessner JF Jr: The matrix metalloproteinase family. In: Matrix Metalloproteinases. Parks WC and Mechan RP (eds). Academic Press, San Diego, CA, pp1-14, 1998.
12. Nelson AR, Fingleton B, Rothenberg ML and Matrisian LM: Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 18: 1135-1149, 2000.
13. Bérubé M, Deschambeault A, Boucher M, Germain L, Petitclerc E and Guérin SL: MMP-2 expression in uveal melanoma: differential activation status dictated by the cellular environment. Mol Vis 11: 1101-1111, 2005.
14. Sato T, Sakai T, Noguchi Y, Takta M, Hirakawa S and Ito A: Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases. Gynecol Oncol 92: 47-56, 2004.
15. Di Nezza LA, Misajon A, Zhang J, Jobling T, Quinn MA, Ostör AG, Nie G, Lopata A and Salamonsen LA: Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion. Cancer 94: 1466-1475, 2002.
16. Cottam DW, Rennie IG, Woods K, Parsons MA, Bunning RA and Rees RC: Gelatinolytic metalloproteinase secretion patterns in ocular melanoma. Invest Ophthalmol Vis Sci 32: 1923-1927, 1992.
17. Fishman DA, Bafetti L, Banionis S, Kearns AS, Chilukuri K and Stack MS: Production of extracellular matrix degrading proteinases by primary cultures of human epithelial ovarian carcinoma cells. Cancer 80: 1457-1463, 1997.
18. Garzetti G, Ciavattini A, Lucarini G, Goteri G, De Nicolis M, Garbisa S, Masiero L, Romanini C and Graziella B: Tissue and serum metalloproteinase (MMP-2) expression in advanced ovarian serous cytstadenocarcinomas: clinical and prognostic implications. Anticancer Res 15: 2799-2804, 1995.
19. Gohji K, Fujomoto N, Hara I, Fujii A, Gotoh A, Okada H, Arakawa S, Kitazawa S, Miyake H, Kamidono S and Nakijima M: Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension. Int J Cancer 79: 96-101, 1998.
20. Schmalfeldt B, Prechtel D, Härting K, Späthe K, Rutke S, Konil E, Fridman R, Berger U, Schmitt M, Kuhn W and Lengyel E: Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benigh to advanced ovarian cancer. Clin Cancer Res 7: 2396-2404, 2001.
21. Maneva-Radicheva L, Ebert U, Dimoudis N and Altankov G: Fibroblast remodeling of adsorbed collagen type IV is altered in contact with cancer cells. Histol Histopathol 23: 833-842, 2008.
22. Ko K, Yazumi S, Yoshikawa K, Konda Y, Nakajima M, Chiba T and Takahashi R: Activation of fibroblast-derived matrix metalloproteinase-2 by colon cancer cells in no-contact co-cultures. Int J Cancer 87: 165-171, 2000.
23. Sato H, Kida Y, Mai M, Endo Y, Sasaki T, Tanaka J and Seiki H: Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene 7: 77-83, 1992.
24. Pyke C, Ralfkiaer E, Huhtala P, Hurskainen T, Dano K and Tryggvason K: Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res 52: 1336-1341, 1992.
25. Pyke C, Kristensen P, Ralfkiaer E, Gröndahl-Hansen J, Eriksen J, Blasi F and Danø K: Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am J Pathol 138: 1059-1067, 1991.
26. Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Rio MC and Chambon P: A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348: 699-704, 1990.
27. Biswas C, Zhang Y, De Castro R, Guo H, Nakamura T, Ktaoka H and Nabeshima K: The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 55: 434-439, 1995.
28. Kataoka H, De Castro R, Zucker S and Biswas C: Tumor cell-derived collagenase-stimulating factor increases expression of interstitial collagenase, stromelysin and 72-kDa gelatinase. Cancer Res 53: 3154-3158, 1993.
29. Liotta LA and Kohn EC: The microenvironment of the tumor-host interface. Nature 411: 375-379, 2001.